Article Details

LIXTE Biotechnology Provides Update On Progress with Proprietary Compound, LB-100, to ...

Retrieved on: 2025-03-27 13:14:27

Tags for this article:

Click the tags to see associated articles and topics

LIXTE Biotechnology Provides Update On Progress with Proprietary Compound, LB-100, to .... View article details on hiswai:

Excerpt

("Roche”) for treatment of unresponsive (MSI Low) metastatic colorectal cancer. Further bolstering of LIXTE's intellectual property portfolio, with ...

Article found on: www.manilatimes.net

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo